United States securities and exchange commission logo





                               August 29, 2023

       Richard M. Brooks
       Chief Executive Officer
       Zumiez Inc.
       4001 204th Street SW
       Lynnwood, Washington 98036

                                                        Re: Zumiez Inc.
                                                            Definitive Proxy
Statement on Schedule 14A
                                                            Filed April 21,
2023
                                                            File No. 000-51300

       Dear Richard M. Brooks:

               We have limited our review of your most recent definitive proxy
statement to those issues
       we have addressed in our comments. Please respond to these comments by
confirming that you
       will revise your future proxy disclosures in accordance with the topics
discussed below.

       Definitive Proxy Statement on Schedule 14A filed April 21, 2023

       Pay Versus Performance Table, page 57

   1.                                                   Please identify each
named executive officer included in the calculation of average non-
                                                        PEO named executive
officer compensation, and the fiscal years in which such persons
                                                        are included. You may
provide this information in a footnote to the pay versus
                                                        performance table. See
Regulation S-K Item 402(v)(3).
   2.                                                   It appears that you
have not provided the relationship disclosures required by Regulation
                                                        S-K Item 402(v)(5).
Please provide this required disclosure in its entirety. Although you
                                                        may provide this
information graphically, narratively, or a combination of the two, this
                                                        disclosure must be
separate from the pay versus performance table required by Regulation
                                                        S-K Item 402(v)(1) and
must provide a clear description of each separate relationship
                                                        indicated in Regulation
S-K Item 402(v)(5)(i)-(iv). Please note, it is not sufficient to state
                                                        that no relationship
exists, even if a particular measure is not used in setting
                                                        compensation.
   3.                                                   We note that you
include Net Sales, Product Margin and Operating Profit as your
                                                        Company-Selected
Measures. Regulation S-K Item 402(v)(2)(vi) permits you to designate
                                                        only one
Company-Selected Measure, which, in your assessment, "represents the most
                                                        important financial
performance measure (that is not otherwise required to be disclosed in
                                                        the table) used by
[you] to link compensation actually paid to [your] named executive
 Richard M. Brooks
Zumiez Inc.
August 29, 2023
Page 2
         officers, for the most recently completed fiscal year, to company
performance." Please
         ensure that you include only one Company-Selected Measure in the
table. You may elect
         to provide in the table one or more performance measures in addition
to the Company-
         Selected Measure, provided that the disclosures about those measures
"may not be
         misleading or obscure the required information, and the additional
performance measures
         may not be presented with greater prominence than the required
disclosure." See Pay
         Versus Performance, Release No. 34   95607 (Apr. 29, 2015) [87 FR
55134 (Sept. 8,
         2022)] at 55159. Also note that each additional measure must also be
accompanied by a
         clear description of the relationship between executive compensation
actually paid to the
         registrant   s PEO, and, on average, to the other NEOs, and that
measure, across each of the
         fiscal years included in the pay versus performance table. See
Regulation S-K Item
         402(v)(5)(iv).

         In addition, for any such measure provided in the pay versus
performance table that is not
         a financial measure under generally accepted accounting principles,
please ensure that you
         provide disclosure showing how the measure is calculated from your
audited financial
         statements, as required by Regulation S-K Item 402(v)(2)(v). If the
disclosure appears in
         a different part of the definitive proxy statement you may satisfy the
disclosure
         requirement by a cross-reference thereto; however, incorporation by
reference to a
         separate filing will not satisfy this disclosure requirement.
4.       It appears that you have not provided the tabular list of at least
three, and up to seven,
         financial performance measures, which in your assessment represent the
most important
         financial performance measures used by you to link compensation
actually paid to
         your named executive officers, for the most recently completed fiscal
year, to your
         performance, as required by Regulation S-K Item 402(v)(6). Please
ensure that you
         provide this required disclosure in its entirety. The Tabular List
should include your
         Company-Selected Measure and any additional measures that you have
elected to include
         in the pay versus performance table.
       Please contact John Stickel at 202-551-3324 or Amanda Ravitz at
202-551-3412 with any
questions.



FirstName LastNameRichard M. Brooks                           Sincerely,
Comapany NameZumiez Inc.
                                                              Division of
Corporation Finance
August 29, 2023 Page 2                                        Disclosure Review
Program
FirstName LastName